vicc

For more news from the Vanderbilt-Ingram Cancer Center, visit their website »

August 16, 2012

VICC debuts outpatient cancer clinic in Springfield

Vanderbilt-Ingram Cancer Center (VICC) has opened a new outpatient cancer clinic on the NorthCrest Medical Center campus in Springfield, Tenn., to bring high quality care to patients in Middle Tennessee and Southern Kentucky.

By VUMC News and Communications
August 16, 2012

Method may refine personalized trials for cancer therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.

By VUMC News and Communications
August 9, 2012

Study tracks how gene may promote lung cancer tumors

Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.

By VUMC News and Communications
brain illustration
August 9, 2012

Study links rare genetic marker to brain cancer

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma.

By VUMC News and Communications
August 2, 2012

Arteaga named to Komen scientific advisory board

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation.

By VUMC News and Communications
August 2, 2012

VICC’s Hassanein lands lung cancer research grant

Mohamed Hassanein, Ph.D., research instructor in Pulmonary Medicine, has received a Career Development Award from the LUNGevity Foundation to work on the development of noninvasive tests to help diagnose lung cancer.

By VUMC News and Communications
August 2, 2012

Proteins may point way to new prostate cancer drug targets

Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.
By VUMC News and Communications
July 19, 2012

VICC adds colon cancer to gene mutation testing

Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer.
By VUMC News and Communications
July 12, 2012

Childhood cancer investigator lands ‘Lemonade Stand’ grant

Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer.
By VUMC News and Communications
July 12, 2012

Photo: Living well through cancer

By VUMC News and Communications
July 12, 2012

New cancer drug shows promise in early testing

By VUMC News and Communications
June 11, 2012

Vanderbilt identifies genes linked to breast cancer chemo resistance

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
By VUMC News and Communications
April 26, 2012

New drug mutes more melanomas

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
By VUMC News and Communications
1 2 3 4 5 … 9